Table 3.
Summary of MRI-based classification systems of adenomyosis.
Author, Year | Classification | Criteria | |
---|---|---|---|
Gordts et al., 2008 [6] | JZ hyperplasia | JZ thickness measuring ≥8 mm but <12 mm on T2-weighted images in women aged 35 years or less. Partial or diffuse type | |
Adenomyosis | JZ thickness ≥12 mm; high-signal intensity myometrial foci; involvement of the outer myometrium: <1/3, <2/3, >2/3 | ||
Adenomyoma | Myometrial mass with indistinct margins of primarily low-signal intensity on all MR sequences. Retrocervical, retrovaginal, fallopian tube, and bladder types | ||
Kishi et al., 2012 [7] | Subtype I (intrinsic) | Adenomyosis has an intimate relationship with inner structural components of the uterus such as the endometrium and JZ | |
Subtype II (extrinsic) | Adenomyosis arising from the outer shell of the uterus, disrupting the serosa but not affecting the inner components | ||
Subtype III (intramural) | Adenomyosis residing solely in the myometrium | ||
Subtype IV (others) | Indeterminate, does not fit into other subtypes | ||
Grimbizis et al., 2014 [25] | Diffuse | Foci of endometrial mucosa scattered throughout the uterine musculature | |
Focal | Adenomyoma | Infiltration of a restricted area of the myometrium with clear borders and mainly solid characteristics | |
Cystic adenomyosis | Single adenomyotic cyst within the myometrium | ||
Polypoid | Typical | Circumscribed endometrial masses composed of endometrioid glands and smooth muscle without architectural or cellular atypia | |
Atypical | A variant of polypoid with atypical endometrial glands and cellular smooth muscle stroma | ||
Other | Endocervical | Adenomyomatous polyps in the cervix that contain epithelial component of endocervical type | |
Retroperitoneal | Nodules thought to arise from metaplasia of Müllerian remnants beneath the peritoneum and in the upper rectovaginal septum | ||
Dashottar et al., 2015 [26] | Focal | Focal widening of the JZ ≥14 mm | |
Diffuse | Even | Consistent JZ thickening ≥14 mm throughout the uterus | |
Uneven | Variable JZ thickening ≥14 mm throughout the uterus | ||
Bazot et al., 2018 [24] | Internal adenomyosis | Focal | Localized intramyometrial tiny cystic component with or without JZ bulging |
Superficial | Disseminated subendometrial tiny cystic component without JZ hypertrophy | ||
Diffuse | Disseminated intramyometrial tiny cystic component with JZ hypertrophy | ||
Adenomyomas | Intramural solid | Ill-defined myometrial lesion with tiny cystic component | |
Intramural cystic | Ill-defined myometrial lesion with hemorrhagic cystic cavity | ||
Submucosal | Ill-defined myometrial lesion with tiny cystic component and intracavitary protrusion | ||
Subserosal | Ill-defined subserous myometrial lesion with tiny cystic component | ||
External adenomyosis | Posterior | Ill-defined posterior myometrial mass associated with posterior deep endometriosis | |
Anterior | Ill-defined subserosal anterior myometrial mass associated with anterior deep endometriosis | ||
Kobayashi et al., 2020 [24] | Affected area | A | Internal adenomyosis, thickness of JZ >12 mm |
B | External adenomyosis, thickness of JZ <8 mm | ||
Size & pattern | A1 or B1 | <1/3 of uterine wall, mostly focal | |
A2 or B2 | <2/3 of uterine wall, can be focal or diffuse | ||
A3 or B3 | >2/3 of uterine wall, mostly diffuse | ||
Concomitant pathologies | C0–5 | None C0, peritoneal endometriosis C1, ovarian endometrioma C2, deep infiltrating endometriosis C3, uterine fibroids C4, others C5 | |
Location | D1–5 | Anterior D1, posterior D2, left lateral D3, right lateral D4, fundus D5 |